Laurion Capital Management »

Xilio Therapeutics shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $64k 117k 0.55
2023-09-30 $294k 139k 2.11
2023-06-30 $374k 143k 2.62
2023-03-31 $454k 143k 3.18
2022-12-31 $384k 143k 2.69
2022-09-30 $416k 143k 2.91
2022-06-30 $417k 143k 2.92

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Meta Platforms Cl A Call Option (META)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Apple (AAPL)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Broadcom Call Option (AVGO)
Ishares Tr Msci Eafe Etf (EFA)
Tesla Motors Call Option (TSLA)
Boeing Company (BA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Home Depot (HD)
JPMorgan Chase & Co. Call Option (JPM)
Adobe Systems Incorporated (ADBE)

View all positions for Laurion Capital Management

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
FMR
RiverVest Venture Management
Rock Springs Capital Management
Atlas Venture Life Science Advisors
Vanguard Group
Balyasny Asset Management
Morgan Stanley
Fil
Geode Capital Management
Bridgeway Capital Management
Millennium Management
BlackRock
SevenBridge Financial
PFG Investments

View all funds holding Xilio Therapeutics